Employee wellness programs can reduce obesity-related healthcare costs Obesity contributes to numerous chronic conditions, including type 2 diabetes, cardiovascular diseases, and certain cancers
Trulicity (Dulaglutide) Eli Lilly LOE 2027 Eli Lillys GLP-1 receptor agonist dulaglutide faces LOE around 2027, but Lillys position in the GLP-1 space has been substantially repositioned by the success of tirzepatide (Mounjaro, Zepbound), a dual GIP/GLP-1 agonist with a superior efficacy profile in clinical trials
J.SaunesM.HveemK
To maximize iron absorption, it is generally recommended to: Take it on an empty stomach (if your stomach can handle it)
A patient whose issue is low desire is not the same patient as one whose issue is vascular arousal, and conflating the two leads to the wrong tool
Guo C, Zhou Y, Zhang X, Shi J, Zu Y, Qi L, et al